ADAR expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.475000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.446000E-01
Normal-vs-Stage2
4.123000E-01
Normal-vs-Stage3
1.916170E-01
Normal-vs-Stage4
9.259000E-01
Stage1-vs-Stage2
9.792400E-01
Stage1-vs-Stage3
1.529640E-01
Stage1-vs-Stage4
4.917600E-01
Stage2-vs-Stage3
1.676180E-01
Stage2-vs-Stage4
4.444600E-01
Stage3-vs-Stage4
1.747790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.075800E-01
Normal-vs-AfricanAmerican
8.038000E-01
Normal-vs-Asian
6.081000E-01
Caucasian-vs-AfricanAmerican
5.962500E-02
Caucasian-vs-Asian
5.366000E-01
AfricanAmerican-vs-Asian
2.872400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.750800E-01
Normal-vs-Female
3.388800E-01
Male-vs-Female
9.017800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.895400E-01
Normal-vs-Age(41-60Yrs)
4.831400E-01
Normal-vs-Age(61-80Yrs)
3.582600E-01
Normal-vs-Age(81-100Yrs)
3.703600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.882000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.222200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.002400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.986810E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.865500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.106030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.034790E-01
Normal-vs-Daily Drinker
1.189790E-01
Normal-vs-Weekly Drinker
5.756400E-01
Normal-vs-Occasional Drinker
5.131200E-01
Normal-vs-Social Drinker
4.846600E-01
Non Drinker-vs-Daily Drinker
8.754800E-01
Non Drinker-vs-Weekly Drinker
2.000400E-01
Non Drinker-vs-Occasional Drinker
4.381700E-02
Non Drinker-vs-Social Drinker
8.195600E-02
Daily Drinker-vs-Weekly Drinker
2.097400E-01
Daily Drinker-vs-Occasional Drinker
4.924400E-02
Daily Drinker-vs-Social Drinker
8.699600E-02
Weekly Drinker-vs-Occasional Drinker
8.002400E-01
Weekly Drinker-vs-Social Drinker
8.977400E-01
Occasional Drinker-vs-Social Drinker
8.826800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.107040E-01
Normal-vs-Grade 2
2.100000E-02
Normal-vs-Grade 3
1.670160E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.335920E-02
Grade 1-vs-Grade 3
3.395600E-03
Grade 1-vs-Grade 4
1.107040E-01
Grade 2-vs-Grade 3
2.935000E-01
Grade 2-vs-Grade 4
2.100000E-02
Grade 3-vs-Grade 4
1.670160E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.194400E-01
Normal-vs-NonDiabetic
2.942200E-01
Diabetic-vs-NonDiabetic
2.991000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.487200E-01
Normal-vs-NoPancreatitis
3.018000E-01
Pancreatitis-vs-NoPancreatitis
9.287000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.277800E-01
Normal-vs-N1
3.796400E-01
N0-vs-N1
9.983400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.001200E-01
Normal-vs-TP53-NonMutant
6.152200E-01
TP53-Mutant-vs-TP53-NonMutant
1.924020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
